Welcome to LookChem.com Sign In|Join Free

CAS

  • or

771-19-7

Post Buying Request

771-19-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

771-19-7 Usage

Type

Chemical compound
Quinoline derivative

Potential properties

Medicinal
Antibacterial
Anticancer

Bacterial growth inhibition

Particularly effective against Staphylococcus aureus strains

Antitumor potential

Inhibits cancer cell growth in vitro

Current status

Subject of ongoing research
Investigating therapeutic properties and pharmaceutical applications

Check Digit Verification of cas no

The CAS Registry Mumber 771-19-7 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 7,7 and 1 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 771-19:
(5*7)+(4*7)+(3*1)+(2*1)+(1*9)=77
77 % 10 = 7
So 771-19-7 is a valid CAS Registry Number.

771-19-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-hydroxy-3,4-dihydroquinolin-2-one

1.2 Other means of identification

Product number -
Other names 1-hydroxy-3,4-dihydro-1H-quinolin-2-one

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:771-19-7 SDS

771-19-7Relevant articles and documents

Reductive cyclizations of nitroarenes to hydroxamic acids by visible light photoredox catalysis

Cismesia, Megan A.,Ischay, Michael A.,Yoon, Tehshik P.

, p. 2699 - 2705 (2013/10/21)

We have developed a photocatalytic reduction of nitroarenes as an efficient, chemoselective route to biologically important N-phenyl hydroxamic acid scaffolds. Optimal conditions call for 2.5 mol% of a ruthenium photocatalyst, visible light irradiation, and a dihydropyridine terminal reductant. Because of the mild nature of the visible light activation, functional groups that might be sensitive to other non-photochemical reduction methods are easily tolerated. Georg Thieme Verlag Stuttgart New York.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 771-19-7